Nogo limits neural plasticity and recovery from injury

Current Opinion in Neurobiology

Volumn 27, Issue , 2014, Pages 53-60

  Schwab, Martin E ^a   Strittmatter, Stephen M ^b  

^a University of Zurich Brain Research Institute   (Switzerland)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOGO A ANTIBODY; PROTEIN NGR1 RECEPTOR; PROTEIN NOGO A; RECEPTOR PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; MYELIN PROTEIN; PROTEIN NOGO;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN INJURY; CELL CYCLE ARREST; CEREBROVASCULAR ACCIDENT; CYTOSKELETON; DISEASE ASSOCIATION; HUMAN; MOLECULAR MECHANICS; MOLECULAR STABILITY; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NERVE FIBER REGENERATION; NONHUMAN; OPTIC NERVE LESION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; SYNAPTIC TRANSMISSION; ANIMAL; CENTRAL NERVOUS SYSTEM DISEASE; CONVALESCENCE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; MYELIN PROTEINS; NEURONAL PLASTICITY; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION;

EID: 84895950053     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2014.02.011     Document Type: Review

References (69)

1. Aguayo A.J., Rasminsky M., Bray G.M., Carbonetto S., McKerracher L., Villegas-P'rez M.P., Vidal-Sanz M., Carter D.A. Degenerative and regenerative responses of injured neurons in the central nervous system of adult mammals. Phil Trans R Soc B 1991, 331:337-343.
2. Schwab M.E. Nogo and axon regeneration. Curr Opin Neurobiol 2004, 14:118-124.
3. Nash M., Pribiag H., Fournier A.E., Jacobson C. Central nervous system regeneration inhibitors and their intracellular substrates. Mol Neurobiol 2009, 40:224-235.
4. Akbik F., Cafferty W.B.J., Strittmatter S.M. Myelin associated inhibitors: a link between injury-induced and experience-dependent plasticity. Exp Neurol 2012, 235:43-52.
5. Schwab M.E. Functions of nogo proteins and their receptors in the nervous system. Nat Rev Neurosci 2010, 11:799-811.
6. Gou X., Zhang Q., Xu N., Deng B., Wang H., Xu L., Wang Q. Spatio-temporal expression of paired immunoglobulin-like receptor-b in the adult mouse brain after focal cerebral ischaemia. Brain Injury 2013, 27:1311-1315.
7. Chivatakarn O., Kaneko S., He Z., Tessier-Lavigne M., Giger R.J. The nogo-66 receptor ngr1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors. J Neurosci 2007, 27:7117-7124.
8. Huebner E.A., Kim B.G., Duffy P.J., Brown R.H., Strittmatter S.M. A multi-domain fragment of nogo-a protein is a potent inhibitor of cortical axon regeneration via nogo receptor 1. J Biol Chem 2011, 286:18026-18036.
9. Sato Y., Iketani M., Kurihara Y., Yamaguchi M., Yamashita N., Nakamura F., Arie Y., Kawasaki T., Hirata T., Abe T., Kiyonari H., et al. Cartilage acidic protein-1b (lotus), an endogenous nogo receptor antagonist for axon tract formation. Science 2011, 333:769-773.
10. Dickendesher T.L., Baldwin K.T., Mironova Y.A., Koriyama Y., Raiker S.J., Askew K.L., Wood A., Geoffroy C.G., Zheng B., Liepmann C.D., Katagiri Y., et al. Ngr1 and ngr3 are receptors for chondroitin sulfate proteoglycans. Nat Neurosci 2012, 15:703-712.
11. Hu F., Strittmatter S.M. The n-terminal domain of nogo-a inhibits cell adhesion and axonal outgrowth by an integrin-specific mechanism. J Neurosci 2008, 28:1262-1269.
12. Kempf A., Tews B., Arzt M.E., Weinmann O., Obermair F.J., Pernet V., Zagrebelsky M., Delekate A., Iobbi C., Zemmar A., et al. The sphingolipid receptor s1pr2 is a receptor for nogo-a repressing synaptic plasticity. PLoS Biol 2013, 12:e1001763. 10.1373/journal.pbio.1001763.
13. Grünewald E., Kinnell H.L., Porteous D.J., Thomson P.A. Gpr50 interacts with neuronal nogo-a and affects neurite outgrowth. Mol Cell Neurosci 2009, 42:363-371.
14. Nakaya N., Sultana A., Lee H.-S., Tomarev S.I. Olfactomedin 1 interacts with the nogo a receptor complex to regulate axon growth. J Biol Chem 2012, 287:37171-37184.
15. Stiles T.L., Dickendesher T.L., Gaultier A., Fernandez-Castaneda A., Mantuano E., Giger R.J., Gonias S.L. Ldl receptor-related protein-1 is a sialic-acid-independent receptor for myelin-associated glycoprotein that functions in neurite outgrowth inhibition by mag and cns myelin. J Cell Sci 2013, 126:209-220.
16. Joset A., Dodd D.A., Halegoua S., Schwab M.E. Pincher-generated nogo-a endosomes mediate growth cone collapse and retrograde signaling. J Cell Biol 2010, 188:271-285.
17. Tan C.L., Kwok J.C.F., Patani R., ffrench-Constant C., Chandran S., Fawcett J.W. Integrin activation promotes axon growth on inhibitory chondroitin sulfate proteoglycans by enhancing integrin signaling. J Neurosci 2011, 31:6289-6295.
18. Peng X., Kim J., Zhou Z., Fink D.J., Mata M. Neuronal nogo-a regulates glutamate receptor subunit expression in hippocampal neurons. J Neurochem 2011, 119:1183-1193.
19. Montani L., Gerrits B., Gehrig P., Kempf A., Dimou L., Wollscheid B., Schwab M.E. Neuronal nogo-a modulates growth cone motility via rho-gtp/limk1/cofilin in the unlesioned adult nervous system. J Biol Chem 2009, 284:10793-10807.
20. Zagrebelsky M., Schweigreiter R., Bandtlow C.E., Schwab M.E., Korte M. Nogo-a stabilizes the architecture of hippocampal neurons. J Neurosci 2010, 30:13220-13234.
21. Craveiro L.M., Hakkoum D., Weinmann O., Montani L., Stoppini L., Schwab M.E. Neutralization of the membrane protein nogo-a enhances growth and reactive sprouting in established organotypic hippocampal slice cultures. Eur J Neurosci 2008, 28:1808-1824.
22. Bareyre F.M., Kerschensteiner M., Raineteau O., Mettenleiter T.C., Weinmann O., Schwab M.E. The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat Neurosci 2004, 7:269-277.
23. Raineteau O., Schwab M.E. Plasticity of motor systems after incomplete spinal cord injury. Nat Rev Neurosci 2001, 2:263-274.
24. van den Brand R., Heutschi J., Barraud Q., DiGiovanna J., Bartholdi K., Huerlimann M., Friedli L., Vollenweider I., Moraud E.M., Duis S., Dominici N., et al. Restoring voluntary control of locomotion after paralyzing spinal cord injury. Science 2012, 336:1182-1185.
25. Liu K., Tedeschi A., Park K.K., He Z. Neuronal intrinsic mechanisms of axon regeneration. Annu Rev Neurosci 2011, 34:131-152.
26. Pun Raymund Y.K., Rolle Isaiah J., LaSarge Candi L., Hosford Bethany E., Rosen Jules M., Uhl Juli D., Schmeltzer Sarah N., Faulkner C., Bronson Stefanie L., Murphy Brian L., Richards David A., et al. Excessive activation of mtor in postnatally generated granule cells is sufficient to cause epilepsy. Neuron 2012, 75:1022-1034.
27. Akhavan D., Cloughesy T.F., Mischel P.S. Mtor signaling in glioblastoma: lessons learned from bench to bedside. Neuro-Oncology 2010, 12:882-889.
28. Zorner B., Schwab M.E. Anti-nogo on the go: from animal models to a clinical trial. Ann N Y Acad Sci 2010, 1198(Suppl 1):E22-E34.
29. Cafferty W.B., McGee A.W., Strittmatter S.M. Axonal growth therapeutics: regeneration or sprouting or plasticity?. Trends Neurosci 2008, 31:215-220.
30. Cafferty W.B., Duffy P., Huebner E., Strittmatter S.M. Mag and omgp synergize with nogo-a to restrict axonal growth and neurological recovery after spinal cord trauma. J Neurosci 2010, 30:6825-6837.
31. Lee J.K., Chow R., Xie F., Chow S.Y., Tolentino K.E., Zheng B. Combined genetic attenuation of myelin and semaphorin-mediated growth inhibition is insufficient to promote serotonergic axon regeneration. J Neurosci 2010, 30:10899-10904.
32. Kempf A., Montani L., Petrinovic M.M., Schroeter A., Weinmann O., Patrignani A., Schwab M.E. Upregulation of axon guidance molecules in the adult central nervous system of nogo-a knockout mice restricts neuronal growth and regeneration. Eur J Neurosci 2013, 38:3567-3579.
33. Dimou L., Schnell L., Montani L., Duncan C., Simonen M., Schneider R., Liebscher T., Gullo M., Schwab M.E. Nogo-a-deficient mice reveal strain-dependent differences in axonal regeneration. J Neurosci 2006, 26:5591-5603.
34. Freund P., Schmidlin E., Wannier T., Bloch J., Mir A., Schwab M.E., Rouiller E.M. Anti-nogo-a antibody treatment promotes recovery of manual dexterity after unilateral cervical lesion in adult primates-re-examination and extension of behavioral data. Eur J Neurosci 2009, 29:983-996.
35. Gonzenbach R.R., Zoerner B., Schnell L., Weinmann O., Mir A., Schwab M.E. Delayed anti-nogo-a antibody application after spinal cord injury shows progressive loss of responsiveness. J Neurotrauma 2012, 29:567-578.
36. Wang X., Duffy P., McGee A.W., Hasan O., Gould G., Tu N., Harel N.Y., Huang Y., Carson R.E., Weinzimmer D., Ropchan J., et al. Recovery from chronic spinal cord contusion after nogo receptor intervention. Ann Neurol 2011, 70:805-821.
37. Mullner A., Gonzenbach R.R., Weinmann O., Schnell L., Liebscher T., Schwab M.E. Lamina-specific restoration of serotonergic projections after nogo-a antibody treatment of spinal cord injury in rats. Eur J Neurosci 2008, 27:326-333.
38. Gonzenbach R.R., Gasser P., Zorner B., Hochreutener E., Dietz V., Schwab M.E. Nogo-a antibodies and training reduce muscle spasms in spinal cord-injured rats. Ann Neurol 2010, 68:48-57.
39. Lindau N.T., Bänninger B.J., Gullo, Good M., Bachmann N.A., Starkey L.C., Schwab L.M.M.E. Rewiring of the corticospinal tract in the adult rat after unilateral stroke and anti-nogo-a therapy. Brain 2013.
40. Tsai S.Y., Papadopoulos C.M., Schwab M.E., Kartje G.L. Delayed anti-nogo-a therapy improves function after chronic stroke in adult rats. Stroke 2011, 42:186-190.
41. Markus T.M., Tsai S.Y., Bollnow M.R., Farrer R.G., O'Brien T.E., Kindler-Baumann D.R., Rausch M., Rudin M., Wiessner C., Mir A.K., Schwab M.E., et al. Recovery and brain reorganization after stroke in adult and aged rats. Ann Neurol 2005, 58:950-953.
42. Wyss A.F., Hamadjida A., Savidan J., Liu Y., Bashir S., Mir A., Schwab M.E., Rouiller E.M., Belhaj-Saif A. Long-term motor cortical map changes following unilateral lesion of the hand representation in the motor cortex in macaque monkeys showing functional recovery of hand functions. Restor Neurol Neurosci 2013, in press.
43. Zhao R.-R., Andrews M.R., Wang D., Warren P., Gullo M., Schnell L., Schwab M.E., Fawcett J.W. Combination treatment with anti-nogo-a and chondroitinase abc is more effective than single treatments at enhancing functional recovery after spinal cord injury. Eur J Neurosci 2013, 38:2946-2961.
44. Pernet V., Schwab M.E. The role of nogo-a in axonal plasticity, regrowth and repair. Cell Tissue Res 2012, 349:97-104.
45. Pernet V., Joly S., Dalkara D., Jordi N., Schwarz O., Christ F. Long-distance axonal regeneration induced by cntf gene transfer is impaired by axonal misguidance in the injured adult optic nerve. Neurobiol Dis 2013, 51:202-213.
46. Luo X., Salgueiro Y., Beckerman S.R., Lemmon V.P., Tsoulfas P., Park K.K. Three-dimensional evaluation of retinal ganglion cell axon regeneration and pathfinding in whole mouse tissue after injury. Exp Neurol 2013, 247:653-662.
47. de Lima S., Koriyama Y., Kurimoto T., Oliveira J.T., Yin Y., Li Y., Gilbert H.-Y., Fagiolini M., Martinez A.M.B., Benowitz L. Full-length axon regeneration in the adult mouse optic nerve and partial recovery of simple visual behaviors. Proc Natl Acad Sci 2012, 109:9149-9154.
48. Fu Q.L., Liao X.X., Li X., Chen D., Shi J., Wen W., Lee D.H., So K.F. Soluble nogo-66 receptor prevents synaptic dysfunction and rescues retinal ganglion cell loss in chronic glaucoma. Invest Ophthalmol Vis Sci 2011, 52:8374-8380.
49. Yang Y., Liu Y., Wei P., Peng H., Winger R., Hussain R.Z., Ben L.-H., Cravens P.D., Gocke A.R., Puttaparthi K., Racke M.K., et al. Silencing nogo-a promotes functional recovery in demyelinating disease. Ann Neurol 2010, 67:498-507.
50. Rudick R.A., Mi S., Sandrock A.W. Lingo-1 antagonists as therapy for multiple sclerosis: In vitro and in vivo evidence. Expert Opin Biol Ther 2008, 8:1561-1570.
51. Petratos S., Ozturk E., Azari M.F., Kenny R., Young Lee J., Magee K.A., Harvey A.R., McDonald C., Taghian K., Moussa L., Mun Aui P., et al. Limiting multiple sclerosis related axonopathy by blocking nogo receptor and crmp-2 phosphorylation. Brain 2012, 135:1794-1818.
52. Karnezis T., Mandemakers W., McQualter J.L., Zheng B., Ho P.P., Jordan K.A., Murray B.M., Barres B., Tessier-Lavigne M., Bernard C.C.A. The neurite outgrowth inhibitor nogo a is involved in autoimmune-mediated demyelination. Nat Neurosci 2004, 7:736-744.
53. Chong S.Y.C., Rosenberg S.S., Fancy S.P.J., Zhao C., Shen Y-AA, Hahn A.T., McGee A.W., Xu X., Zheng B., Zhang L.I., Rowitch D.H., et al. Neurite outgrowth inhibitor nogo-a establishes spatial segregation and extent of oligodendrocyte myelination. Proc Natl Acad Sci 2012, 109:1299-1304.
54. Abel R., Baron H.C., Casha S., Harms J., Hurlbert J., Kucher K., Maier D., Thietje R., Weidner N., Curt A. Therapeutic anti-nogo-a antibodies in acute spinal cord injury: safety and pharmacokinetic data from an ongoing first-in-human trial. ISCOS Meeting 2011 2011.
55. Cramer S.C., Abila B., Scott N.E., Simeoni M., Enney L.A. Safety, pharmacokinetics, and pharmacodynamics of escalating repeat doses of gsk249320 in patients with stroke. Stroke 2013, 44:1337-1342.
56. McGee A.W., Yang Y., Fischer Q.S., Daw N.W., Strittmatter S.M. Experience-driven plasticity of visual cortex limited by myelin and nogo receptor. Science 2005, 309:2222-2226.
57. Pizzorusso T., Medini P., Berardi N., Chierzi S., Fawcett J.W., Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002, 298:1248-1251.
58. Raiker S.J., Lee H., Baldwin K.T., Duan Y., Shrager P., Giger R.J. Oligodendrocyte-myelin glycoprotein and nogo negatively regulate activity-dependent synaptic plasticity. J Neurosci 2010, 30:12432-12445.
59. Lee H., Raiker S.J., Venkatesh K., Geary R., Robak L.A., Zhang Y., Yeh H.H., Shrager P., Giger R.J. Synaptic function for the nogo-66 receptor ngr1: Regulation of dendritic spine morphology and activity-dependent synaptic strength. J Neurosci 2008, 28:2753-2765.
60. Delekate A., Zagrebelsky M., Kramer S., Schwab M.E., Korte M. Nogoa restricts synaptic plasticity in the adult hippocampus on a fast time scale. Proc Natl Acad Sci U S A 2011, 108:2569-2574.
61. Tews B., Schönig K., Arzt M.E., Clementi S., Rioult-Pedotti M.-S., Zemmar A., Berger S.M., Schneider M., Enkel T., Weinmann O., Kasper H., et al. Synthetic microrna-mediated downregulation of nogo-a in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function. Proc Natl Acad Sci U S A 2013, 110:6583-6588.
62. Wills Z.P., Mandel-Brehm C., Mardinly A.R., McCord A.E., Giger R.J., Greenberg M.E. The nogo receptor family restricts synapse number in the developing hippocampus. Neuron 2012, 73:466-481.
63. Petrinovic M.M., Hourez R., Aloy E.M., Dewarrat G., Gall D., Weinmann O., Gaudias J., Bachmann L.C., Schiffmann S.N., Vogt K.E., Schwab M.E. Neuronal nogo-a negatively regulates dendritic morphology and synaptic transmission in the cerebellum. Proc Natl Acad Sci U S A 2013, 110:1083-1088.
64. Akbik F.V., Bhagat S.M., Patel P.R., Cafferty W.B., Strittmatter S.M. Anatomical plasticity of adult brain is titrated by nogo receptor 1. Neuron 2013, 77:859-866.
65. Karlen A., Karlsson T.E., Mattsson A., Lundstromer K., Codeluppi S., Pham T.M., Backman C.M., Ogren S.O., Aberg E., Hoffman A.F., Sherling M.A., et al. Nogo receptor 1 regulates formation of lasting memories. Proc Natl Acad Sci U S A 2009, 106:20476-20481.
66. Lai C.S., Franke T.F., Gan W.B. Opposite effects of fear conditioning and extinction on dendritic spine remodelling. Nature 2012, 483:87-91.
67. Budel S., Padukkavidana T., Liu B.P., Feng Z., Hu F., Johnson S., Lauren J., Park J.H., McGee A.W., Liao J., Stillman A., et al. Genetic variants of nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci 2008, 28:13161-13172.
68. Willi R., Schwab M.E. Nogo and nogo receptor: relevance to schizophrenia?. Neurobiol Dis 2013, 54:150-157.
69. Willi R., Weinmann O., Winter C., Klein J., Sohr R., Schnell L., Yee B.K., Feldon J., Schwab M.E. Constitutive genetic deletion of the growth regulator nogo-a induces schizophrenia-related endophenotypes. J Neurosci 2010, 30:556-567.